Investor Relations

Board of Directors Of Al Hammadi Holding Company (Al Hammadi) is pleased to present to you the annual reports for the fiscal years, which includes the results of the Company’s business, its achievements and the most important objectives that have been achieved during the year in addition to the financial statements for the year ended , information about the Board and its committees and executive management and the external Auditor BDO Dr. Mohamed Al-Amri & Co .

Operational & Financial Review 2023

Al Hammadi recorded revenues of 1,177 million Riyals in 2023 , a 5% increase from 1,123 million Riyals recorded in 2022 and Gross profit amounted 433 million Riyals in 2023 ,a 3% increase from 416 million Riyals recorded in 2022 ,and the operating profit reached 347 million riyals in 2023 ,a 17% increase from 292 million Riyals recorded in 2022, and the net profit reached 303 million riyals ,an 18% increase from 257 million Riyals recorded in 2022 .

3%

0 M
SAR

Gross Profit

5%

0 M
SAR

Revenue

17%

0 M
SAR

Operating Profit

18%

0 M
SAR

Net Profit

Al Hammadi Holding Company

Trading NameAlHammadi Holding
ISIN CODESA13J051UJH4
SectorHealthCare
Number of Employees3245
Investor Relations
IR@ALHAMMADI.COM

Equity Profile

Authorized Capital (SAR)1,600,000,000
Issued Shares160,000,000
Paid Capital (SAR)1,600,000,000
Par Value/Share10
Paid Up Value/Share10
Cash Flow2023-12-31
Net Cash From Operating Activities350,954
Net Cash From Investing Activities-54,782
Net Cash From Financing Activities-231,537
Cash and Cash Equivalents, Beginning of the Period60,602
Cash and Cash Equivalents, End of the Period125,237
All Figures inThousands
All Currency InSAR
All Currency In2024-03-19
Cash Flow31-03-20242023-09-30
Net Cash From Operating Activitie142,879342,496
Net Cash From Investing Activities-5,990-47,095
Net Cash From Financing Activities-56,110-170,261
Cash and Cash Equivalents, Beginning of the Period125,23760,602
Cash and Cash Equivalents, End of the Period206,016185,743
All Figures inThousandsThousands
All Currency InSARSAR
Last Update Date19-05-202405-11-2023

Annual Report 2022

Board Of Directors Report

During 2022, Al Hammadi Holding Company was able to deliver a solid performance by continuing to deliver short-term growth and profitability while pursuing its long-term value creation strategy . Al Hammadi Holding’s efforts throughout 2022 saw it end the year ideally placed to continue delivering world-class care to its patients and further growth and value for its shareholders in 2023 and beyond 

Detailed Reports and Statements

Financial Statements 2023
DescriptionQ1Q2Q3ِAnnual
Financial Statements
Earnings Release
Annual Board Of Directors Report
Annual Investor Presentation
Financial Statements 2022
DescriptionQ1Q2Q3Annual
Financial Statements
Earnings Release
Annual Board Of Directors Report
Annual Investor Presentation
Financial Statements 2021
DescriptionQ1Q2Q3Annual
Financial Statements
Annual Board Of Directors Report
Annual Investor Presentation
Financial Statements 2020
DescriptionQ1Q2Q3Annual
Financial Statements
Annual Board Of Directors Report

Newsletter Subscribe Now

Pharmaceutical Services

Pharmaceutical Services Company, a subsidiary of Al Hammadi Holding, is a leading provider of essential medications, vaccinations, and drug distribution services. As a key component of Al Hammadi’s comprehensive health care offering, the Pharmaceutical Services Company plays a vital role in ensuring that patients have access to the necessary treatments to support their health and well-being.

Continuing Medical Education (CME)

The Continuing Medical Education (CME) was established in 1985 to meet the education and training needs of all hospital staff, whether medical personnel, doctors or non-medical staff nurses, assistants or technicians.

Training Institutes Women

The Support Services Institutes for Training opened branches for (women) in Riyadh, Kingdom of Saudi Arabia in 2020, after the complete acquisition (100%) of Najd Training Institutes, which was established in 1986 AD. Thus, the Support Services Institutes have become one of the leading and specialized institutes in the field of training and education. and development.

Training Institutes Men

The Support Services Institutes for Training opened branches for(Men) in Riyadh, Kingdom of Saudi Arabia in 2020, after the complete acquisition (100%) of Najd Training Institutes, which was established in 1986 AD. Thus, the Support Services Institutes have become one of the leading and specialized institutes in the field of training and education. and development.

Sudair Pharmaceutical

Sudair Pharmaceutical Company (SPC) is a leading Saudi-based pharmaceutical firm specializing in specialty care medications. Established in 2014, SPC aims to address unmet medical needs in Saudi Arabia and the MENA region, with a focus on cancer-fighting medications and other high-tech treatments for chronic and life-threatening diseases. Al Hammadi Holding Company owns 35% of SPC’s shares, bolstering its commitment to improve healthcare provision and secure the supply of advanced pharmaceuticals. SPC’s innovative business model, international partnerships, and dedication to integrity, quality, innovation, and community service make it an integral player in achieving KSA’s 2030 vision for better health outcomes.

Biopharma Industrial Park

The Biopharma Industrial Park is a progressive subsidiary of Al Hammadi Holding, operating at the forefront of biotechnology and life sciences innovation. As a pivotal contributor to Al Hammadi’s comprehensive health care services, the Biopharma Industrial Park is committed to driving advancements in medical research, development, and production. Its focus on cutting-edge technologies and scientific expertise enables the organization to make significant strides in improving patient care, as well as advancing the medical sector within the Kingdom of Saudi Arabia and beyond.

Construction & Maintenance

The Construction and Maintenance Company is a subsidiary of Al Hammadi Holding, specializing in providing high-quality hospital maintenance, engineering works, and other related services. As an integral part of the Al Hammadi group, this company plays a crucial role in ensuring the smooth and efficient functioning of health care facilities while maintaining a safe and comfortable environment for patients and medical staff, the company recently obtained certificates in quality, safety and environmental management.

Home Medical Care

Home Medical Care, a subsidiary of Al Hammadi Holding, provides comprehensive and personalized healthcare services to patients in the comfort of their own homes. This innovative approach to healthcare delivery aims to enhance patient satisfaction, reduce hospital readmissions, and improve overall patient outcomes. By offering a wide range of medical services in a familiar and comfortable environment, Home Medical Care strives to promote patient well-being and independence.

Telemedicine

Telemedicine Company, a subsidiary of Al Hammadi Holding, is at the forefront of revolutionizing healthcare delivery by leveraging advanced technology to provide remote medical services. This innovative approach to healthcare enables patients to access quality medical care from the comfort of their homes or workplaces, eliminating geographical barriers and reducing the burden on traditional healthcare facilities.

Unified Procurement

Unified Procurement, a subsidiary of Al Hammadi Holding, is a specialized company responsible for managing all medical and non-medical hospital purchases and supplies. As an integral part of Al Hammadi’s comprehensive health care services, Unified Procurement plays a vital role in ensuring that hospitals and clinics have access to the necessary equipment, supplies, and consumables needed to provide high-quality care to their patients.

Arabian Hospitality

Arabian Hospitality, a subsidiary of Al Hammadi Holding, is a prominent player in the domain of hospital support services, dedicated to maintaining the highest standards of hygiene, laundry, medical staff attire, and food services for patients. As an integral part of the Al Hammadi Holding group, Arabian Hospitality ensures a seamless and comfortable experience for both patients and medical staff, contributing to the overall excellence of the group’s health care offerings, the company recently obtained the certificates of Quality Management, Food Safety, Hazard Analysis and Critical Control Points.

Al Hammadi Hospital Al Narjis

Al Narjis Hospital – Expected launch in 2028 .Building on this, Al Hammadi is expecting to launch its fourth hospital in 2028. The facility will have a capacity of 200 rooms and 120 clinics and will house two centers of excellence focused on rehabilitation and plastic surgery. The facility will be located in Al Narjis neighborhood in the north of the Kingdom’s capital.

Al Hammadi Hospital Al Olaya

Al Olaya Hospital – Expected Launch in 2026 .Al Olaya Hospital was Al Hammadi’s first facility, originally launched back in 1985. At its peak, the facility was home to 200 inpatient rooms and 74 outpatient clinics. The facility was temporarily shut down in the final months of 2021 as management kicked off an extensive renovation plan aimed at constructing a new facility with a new infrastructure and a broader service offering. The revamped facility, which is planned to reopen in 2026, will have a capacity of 200 rooms and 120 clinics and will operate two centers of excellence focused on sports medicine and oncology. The facility is located in the Al Olaya neighborhood of Riyadh, which has historically been a business, commerce, and leisure hub in the city, rendering it a natural residential destination for expats and a large number of Saudi citizens.

Al Hammadi Hospital Al Suwaidi

Launched in 2015, Al Suwaidi Hospital is located in a strategic southwest neighborhood of KSA’s capital. Today, the facility houses 300 inpatient rooms, 80 outpatient clinics, and 13 operating rooms. The facility also has a cardiac catheterization room, two upper and lower endoscopy rooms, a kidney stone treatment room, and a lithotripsy room. The facility is equipped with the highest quality machinery and medical technology in the market, and services are provided by highly trained and experienced medical professionals. As of year-end 2022, 160 rooms were operational at the facility, with the remaining unutilized rooms offering easy-to-ramp-up capacity to match growing demand. The facility caters to both a significant pool of patients associated with the MOH and private insurance patients primarily from the medium and medium-upper class segment.

Al Hammadi Hospital Al Nuzha

Located in a northeast neighborhood of Riyadh and officially inaugurated in 2018, Al Nuzha Hospital was originally launched to cater predominately to medium and upper-medium class patients, leveraging its 300-room capacity, 100 outpatient clinics, and 13 operating rooms. In 2022, the facility continued its premiumization, converting double rooms into single rooms to cater to increasing demand from higher-income class A/VIP patients and enabling the Group to capitalize on the important growth opportunities offered by this expanding segment. Today, Al Nuzha Hospital offers a comprehensive range of medical services, all provided by the facility’s highly experienced medical staff